Accession Number: | 0001209191-20-055054 |
Date: | 2020-10-14 |
Issuer: | PACIRA BIOSCIENCES, INC. (PCRX) |
Original Submission Date: |
STACK DAVID M
C/O PACIRA BIOSCIENCES, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY, NJ 07054
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-10-14 | M | 30,000 | a | $10.81 | 203,377 | direct | ||
COMMON STOCK | 2020-10-14 | S | 30,000 | d | $55.53 | 173,377 | direct | ||
COMMON STOCK | 2020-10-15 | M | 30,000 | a | $10.81 | 203,377 | direct | ||
COMMON STOCK | 2020-10-15 | S | 30,000 | d | $55.00 | 173,377 | direct | ||
COMMON STOCK | 2020-10-16 | M | 30,000 | a | $10.81 | 203,377 | direct | ||
COMMON STOCK | 2020-10-16 | S | 30,000 | d | $55.56 | 173,377 | direct | ||
COMMON STOCK | 2020-10-14 | 0 | $0.00 | 18,596 | indirect | f2 | |||
COMMON STOCK | 2020-10-14 | 0 | $0.00 | 1,208 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 10.81 | 2020-10-14 | deemed execution date | M | 30,000 (d) | 2022-06-05 | common stock 30,000 | $10.81 | 233,670 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 10.81 | 2020-10-15 | deemed execution date | M | 30,000 (d) | 2022-06-05 | common stock 30,000 | $10.81 | 203,670 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 10.81 | 2020-10-16 | deemed execution date | M | 30,000 (d) | 2022-06-05 | common stock 30,000 | $10.81 | 173,670 | direct |
ID | footnote |
---|---|
f1 | the option exercise and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person in accordance with rule 10b5-1 of the securities exchange act of 1934. |
f2 | mr. stack is the general partner of stack schroon mohawk flp. mr. stack and his wife are the owners of lck investment llc. |
f3 | the option vested and became exercisable as to 25% of the option shares on june 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |
f4 | reflects the transfer of stock options to purchase 243,129 shares of common stock previously held indirectly by the reporting person through lck investment llc to the reporting person directly. |